Bard Brachytherapy, Inc.: Medical Device Recalls in 2018

Updated on March 25, 2026.

According to to data from the FDA, there was 1 medical device recall made by Bard Brachytherapy, Inc. in 2018. See the detail of the recall below.

You can see similar recalls for other firms.

Data Source: FDA.

See this for other years:

BARD¿ BrachySource¿ Iodine125 radioactive seeds consist of a welded titanium capsule containing the I125 absorbed onto a nickel / copper-coated, gold-cored aluminum wire (reference Figure 1 below). The I125 has a half-life of 59.6 days and decays by electron capture with the emission of characteristic photons and Auger electrons. The principal photon emissions are 27.4 and 31 keV x-rays and 35.5 keV gamma. The titanium wall of the BrachySource¿ Seed Implants absorbs the electrons.